Powered by

Internationally Recognized Top Neurosurgeon Joins the Medical Advisory Board of Oncotelic

Jul 16, 2019 - GlobeNewswire
Board and Executive Moves

AGOURA HILLS, Calif., July 16, 2019 (GLOBE NEWSWIRE) -- Oncotelic Inc. ("Oncotelic"), a wholly owned subsidiary of Mateon Therapeutics Inc. (OTCQB:MATN) dedicated to development of innovative treatments for cancer, announced today that Dr. John H. Sampson, an internationally recognized neurosurgeon and clinical scholar with deep knowledge and experience in treatment of brain tumors, has joined its Medical Advisory Board (MAB).  Dr. Sampson will provide expert advice and strategic guidance to ...